Clinical Trial Update: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase [Phase 1]

View source ↗

Summary

This update summarizes a Phase 1 study of tipifarnib and bortezomib in patients with acute leukemia and blast-phase chronic myeloid leukemia. The trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Basophilic Leukemia
• Blast Phase Chronic Myeloid Leukemia
• Eosinophilic Leukemia

Drugs mentioned

• Bortezomib (bortezomib)
• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia | Phase 1 | Status: COMPLETED